Strides Pharma Science Releases FY26 Sustainability Report
Strides Pharma Science Ltd has released its Sustainability Report for FY26, prepared in accordance with GRI Standards 2021 and SASB standards. The report details the company's non-financial performance across Environmental, Social, and Governance (ESG) parameters, outlining its sustainability framework, strategic plans, challenges, and long-term goals. It also maps initiatives against the United Nations Sustainable Development Goals, underscoring a commitment to responsible business practices and sustainable value creation. The reporting boundary includes all manufacturing facilities, R&D centers, and corporate offices in India, along with subsidiaries in multiple international locations, representing approximately 97% of consolidated revenue.
Key Highlights
- Strides Pharma Science released its FY26 Sustainability Report.
- Report follows GRI Standards 2021 and SASB standards.
- Covers ESG performance, strategy, challenges, and goals.
- Aligns initiatives with UN Global Compact and SDGs.
- Reporting boundary covers India and international subsidiaries.
Price Impact
More from STAR